NA89
NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
27/03/2021
Voltar para busca
Dado oficial do USPTO
PIERIS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
48
Atualização mais recente
27/03/2021
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
1, 5, 42
Data de depósito
23/12/2008
Data de registro
21/12/2010
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
27/03/2021
Última transação
27/03/2021
Escritório responsável
United States Patent and Trademark Office
Código da situação
800
Cadastro oficial
Principal Register
Fundamento do pedido
Intent to use
Código do desenho
4
Tipo de titular
16
Localização do titular
Hallbergmoos, DE
Examinador
SHARPER JR, SAM
Unidade examinadora
L80
Localização atual
GENERIC WEB UPDATE
Titulares e representantes
Titulares
PIERIS PHARMACEUTICALS GMBH
PIERIS AG
Representantes
Michael J. Leonard Fox Rothschild LLP
Classificação técnica
Classes Nice
Classe 1Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 1
Chemicals used in industry and scienceconjugates of organic and inorganic chemicals with polypeptidesproteinsartificial polypeptides and artificial proteins produced by genetic engineeringnucleic acid molecule encoding polypeptides and proteins all for scientific and research use; Bio-chemicals and biopharmaceuticalspolypeptidesprotein arraysartificial polypeptides produced by genetic engineeringfor scientific and research useother than medical and veterinary purposes; diagnostic preparations for scientific and research use; diagnostic reagents for scientific and research use; diagnostic preparations for clinical and medical laboratory use and diagnostic reagents for clinical and medical laboratory use
Classe 5
Pharmaceuticalveterinary and sanitary preparationsconjugates of organic and inorganic chemicals with polypeptidesproteinsartificial polypeptidesartificial proteins produced by genetic engineeringall for medical purposesmedication for treatment of cancermedication for treatment of auto-immune diseasesmedication for eye diseasesvaccinesmedication for treatment of bacterial infectionsmedication for treatment of fungal infectionmedication for treatment of infectious diseasesmedication for treatment of inflammatory diseasesmedication for viral diseasespain relief medicationmedication for animal skin care and medication for dermatology ; medical diagnostic reagents
Classe 42
Research in science and industryresearch in the areas of biochemistrydiagnostics and pharmaceuticals; bio-chemistry or pharmaceutical laboratories; laboratory research in the field of life scienceshealthcare and medicinal researchagro-chemistryveterinary usesenvironmental technologyfood and flavor industryprotein-chip industry
Publicações
Histórico de despachos e eventos da marca no USPTO.
48 publicações encontradas
RNL1
REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
27/03/2021
89AG
REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
27/03/2021
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
27/03/2021
E89R
TEAS SECTION 8 & 9 RECEIVED
15/12/2020
REM2
COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
21/12/2019
NA85
NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED
13/02/2017
C15A
REGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.
13/02/2017
APRE
CASE ASSIGNED TO POST REGISTRATION PARALEGAL
13/02/2017
E815
TEAS SECTION 8 & 15 RECEIVED
06/12/2016
ASCK
ASSIGNMENT OF OWNERSHIP NOT UPDATED AUTOMATICALLY
14/09/2016
ASGN
AUTOMATIC UPDATE OF ASSIGNMENT OF OWNERSHIP
31/08/2016
REM1
COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
21/12/2015
TCCA
TEAS CHANGE OF CORRESPONDENCE RECEIVED
04/06/2013
R.PR
REGISTERED-PRINCIPAL REGISTER
21/12/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
05/10/2010
PUBO
PUBLISHED FOR OPPOSITION
05/10/2010
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
01/09/2010
ALIE
ASSIGNED TO LIE
01/09/2010
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
18/08/2010
XAEC
EXAMINER'S AMENDMENT ENTERED
18/08/2010
GNEN
NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
18/08/2010
GNEA
EXAMINERS AMENDMENT E-MAILED
18/08/2010
CNEA
EXAMINERS AMENDMENT -WRITTEN
18/08/2010
ZZZX
PREVIOUS ALLOWANCE COUNT WITHDRAWN
17/08/2010
PBCR
WITHDRAWN FROM PUB - OG REVIEW QUERY
15/08/2010
CHPB
POST PUBLICATION AMENDMENT - ENTERED
03/08/2010
ADBS
1(B) BASIS DELETED; NEW BASIS REQUESTED
21/07/2010
PCBG
PETITION TO DIRECTOR - CHANGE BASIS - GRANTED
20/07/2010
APET
ASSIGNED TO PETITION STAFF
14/07/2010
IUCN
NOTICE OF ALLOWANCE CANCELLED
09/07/2010
TPAD
TEAS PETITION TO AMEND BASIS RECEIVED
09/07/2010
ARAA
ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
16/06/2010
REAP
TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
16/06/2010
NOAM
NOA MAILED - SOU REQUIRED FROM APPLICANT
26/01/2010
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
03/11/2009
PUBO
PUBLISHED FOR OPPOSITION
03/11/2009
PREV
LAW OFFICE PUBLICATION REVIEW COMPLETED
29/09/2009
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
24/09/2009
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
23/09/2009
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
23/09/2009
ALIE
ASSIGNED TO LIE
23/09/2009
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
22/09/2009
GNRN
NOTIFICATION OF NON-FINAL ACTION E-MAILED
23/03/2009
GNRT
NON-FINAL ACTION E-MAILED
23/03/2009
CNRT
NON-FINAL ACTION WRITTEN
23/03/2009
DOCK
ASSIGNED TO EXAMINER
17/03/2009
NWAP
NEW APPLICATION ENTERED
29/12/2008
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace PIERIS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.